Amid the urgency and uncertainty of the COVID-19 pandemic, millions of people continue to struggle with serious health conditions like chronic pain and opioid use disorder – with veterans and military service members at greater risk for both. Since before the pandemic hit, the PMC has been working to understand how best to use nonpharmacological approaches for pain management in innovative and integrative models of pain care delivery. The PMC’s 11 “pragmatic trials” are conducting real-world research within large health systems that provide routine care to military service members and veterans, thus providing an opportunity to help millions disabled by the burdens of pain. As the COVID-19 pandemic hit, the PMC adapted its research as needed to continue its progress in advancing research on nonpharmacological pain management during this unprecedented disruption in research, healthcare, and everyday routines that affect how people live with pain.
The response by the Pain Management Collaboratory to the COVID-19 pandemic was recently published in Translational Behavioral Medicine. The brief report, led by Brian C. Coleman, DC, highlights the collaborative response by the investigators of the PMC’s pragmatic trials, the PMC’s domain-oriented work groups, and the Pain Management Collaboratory Coordinating Center.
Adapting to disruption of research during the COVID-19 pandemic while testing nonpharmacological approaches to pain management
Brian C. Coleman,, Jacob Kean, Cynthia A. Brandt, Peter Peduzzi, Robert D. Kerns, on behalf of the NIH-DoD-VA Pain Management Collaboratory
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society of Behavioral Medicine.